| Nanomedicine therapeutic approaches to overcome cancer drug resistance JL Markman, A Rekechenetskiy, E Holler, JY Ljubimova Advanced drug delivery reviews 65 (13-14), 1866-1879, 2013 | 761 | 2013 |
| Impact of the immune system and immunotherapy in colorectal cancer JL Markman, SL Shiao Journal of gastrointestinal oncology 6 (2), 208, 2015 | 235 | 2015 |
| Blood–brain barrier permeable nano immunoconjugates induce local immune responses for glioma therapy A Galstyan, JL Markman, ES Shatalova, A Chiechi, AJ Korman, R Patil, ... Nature Communications 10 (1), 3850, 2019 | 226 | 2019 |
| C9orf72 in myeloid cells suppresses STING-induced inflammation ME McCauley, JG O’Rourke, A Yáñez, JL Markman, R Ho, X Wang, ... Nature 585 (7823), 96-101, 2020 | 207 | 2020 |
| MRI virtual biopsy and treatment of brain metastatic tumors with targeted nanobioconjugates: nanoclinic in the brain R Patil, AV Ljubimov, PR Gangalum, H Ding, J Portilla-Arias, S Wagner, ... ACS nano 9 (5), 5594-5608, 2015 | 91 | 2015 |
| Nanobiopolymer for direct targeting and inhibition of EGFR expression in triple negative breast cancer S Inoue, R Patil, J Portilla-Arias, H Ding, B Konda, A Espinoza, D Mongayt, ... PLoS One 7 (2), e31070, 2012 | 75 | 2012 |
| Toxicity and efficacy evaluation of multiple targeted polymalic acid conjugates for triple-negative breast cancer treatment JY Ljubimova, J Portilla-Arias, R Patil, H Ding, S Inoue, JL Markman, ... Journal of drug targeting 21 (10), 956-967, 2013 | 57 | 2013 |
| Sex-specific effects of the Nlrp3 inflammasome on atherogenesis in LDL receptor-deficient mice S Chen, JL Markman, K Shimada, TR Crother, M Lane, A Abolhesn, ... Basic to Translational Science 5 (6), 582-598, 2020 | 48 | 2020 |
| Oxidative DNA damage accelerates skin inflammation in pristane-induced lupus model G Tumurkhuu, S Chen, EN Montano, D Ercan Laguna, G De Los Santos, ... Frontiers in immunology 11, 554725, 2020 | 45 | 2020 |
| Loss of testosterone impairs anti-tumor neutrophil function JL Markman, RA Porritt, D Wakita, ME Lane, D Martinon, M Noval Rivas, ... Nature communications 11 (1), 1613, 2020 | 45 | 2020 |
| Polymalic acid nanobioconjugate for simultaneous immunostimulation and inhibition of tumor growth in HER2/neu-positive breast cancer H Ding, G Helguera, JA Rodríguez, J Markman, R Luria-Pérez, ... Journal of Controlled Release 171 (3), 322-329, 2013 | 42 | 2013 |
| Interleukin-1 beta–mediated sex differences in Kawasaki disease vasculitis development and response to treatment RA Porritt, JL Markman, D Maruyama, B Kocaturk, S Chen, TJA Lehman, ... Arteriosclerosis, thrombosis, and vascular biology 40 (3), 802-818, 2020 | 41 | 2020 |
| Treg cells in pancreatic lymph nodes: the possible role in diabetogenesis and β cell regeneration in a T1D model BK Nti, JL Markman, S Bertera, AJ Styche, RJ Lakomy, VM Subbotin, ... Cellular & molecular immunology 9 (6), 455-463, 2012 | 34 | 2012 |
| Gene expression changes in rat brain after short and long exposures to particulate matter in Los Angeles basin air: Comparison with human brain tumors JY Ljubimova, MT Kleinman, NM Karabalin, S Inoue, B Konda, ... Experimental and Toxicologic Pathology 65 (7-8), 1063-1071, 2013 | 30 | 2013 |
| Time to evolve: predicting engineered T cell-associated toxicity with next-generation models E Donnadieu, M Luu, M Alb, B Anliker, S Arcangeli, C Bonini, ... Journal for immunotherapy of cancer 10 (5), 2022 | 27 | 2022 |
| T-cell-intrinsic receptor interacting protein 2 regulates pathogenic T helper 17 cell differentiation K Shimada, RA Porritt, JL Markman, JG O’rourke, D Wakita, MN Rivas, ... Immunity 49 (5), 873-885. e7, 2018 | 26 | 2018 |
| Time 2EVOLVE: predicting efficacy of engineered T-cells–how far is the bench from the bedside? S Guedan, M Luu, D Ammar, P Barbao, C Bonini, P Bousso, CJ Buchholz, ... Journal for Immunotherapy of Cancer 10 (5), 2022 | 18 | 2022 |
| Resistance to receptor-blocking therapies primes tumors as targets for HER3-homing nanobiologics JD Sims, JM Taguiam, F Alonso-Valenteen, J Markman, H Agadjanian, ... Journal of Controlled Release 271, 127-138, 2018 | 12 | 2018 |
| Author Correction: Blood–brain barrier permeable nano immunoconjugates induce local immune responses for glioma therapy A Galstyan, JL Markman, ES Shatalova, A Chiechi, AJ Korman, R Patil, ... Nature communications 11 (1), 6170, 2020 | 8 | 2020 |
| Polymalic acid nanobioconjugate for simultaneous inhibition of tumor growth and immunostimulation in HER2/neu-positive breast cancer H Ding, G Helguera, JA Rodríguez, J Markman, R Luria-Pérez, ... Journal of controlled release: official journal of the Controlled Release …, 2013 | 7 | 2013 |
